b stem cell coin white paper ver 1 0 stem cell coin regenerative medicine world xc2 xa9stem cell project x0ctable contents important reminder p 3 important items requiring confirmation p 4 ico p 5 details stem cell coin p 6 road map p 7 concepts project p 8 brief overview project p 10 market sizes growth potential regenerative medicine p 15 stem cell p 18 indicated clinical cases p 21 pathological diagnostic imaging systems ai blockchain p 25 concept virtual clinic platform p 29 brief overview jasarm p 32 business expansion map p 35 brief overview token sale p 36 token distribution p 37 bonuses major token holders p 38 project team p 39 disclaimer p 40 xc2 xa9stem cell project 2 x0cdisclaimer white paper describes sale stem cell coin scc described paper scc cryptocurrency designed use services provided stem cell project team affiliate companies scc token created basis ethereum network token nature securities legal jurisdiction paper inviting investors offering securities means legal jurisdiction note purchasing scc definitive non refundable individual company organization consider risks purchasing scc costs benefits carefully information contained paper document comprehensive paper represent privity contract company token purchasers accuracy reliability integrity materials included paper provided sites association ico guaranteed accept legal responsibilities companies individuals scc represent warrant promise truth accuracy integrity kind information described paper scc intend scc disclaims representation warranty promise xc2 xa9stem cell project 3 x0cimportant items requiring confirmation purchasing scc carry risk consider purchasers accepted following risks buying coins xe2 x80 xa2 xe2 x80 xa2 xe2 x80 xa2 xe2 x80 xa2 xe2 x80 xa2 xe2 x80 xa2 purchasers recognize services stem cell project currently development major modification occur period start services purchasers understand expectations forms features stem cell project fulfilled reasons purchasers understand cryptocurrency exchanges deny connection project scc devotes best efforts connect major exchanges result liquidity provided platform lower expected paper purchasers understand date official release late scc devotes best efforts start scheduled broad fluctuations value scc lowering reasons scc issued neo blockchain transfer scc purchasers xe2 x80 x99 capability holding coin safely affected troubles neo protocol unexpected function xe2 x80 xa2 xc2 xa9stem cell project 4 x0cwhat ico ico initial coin offering method financial arrangements issuing original digital token selling assign equity like stock funding simply sell token like rewardbased crowdfunding token recognized xe2 x80 x9ccryptocurrency xe2 x80 x9d time selling means ico method xe2 x80 x9cfinancial arrangements xe2 x80 x9d strict definition selling token buy xe2 x80 x9cinvestors xe2 x80 x9d project xe2 x80 x9cpurchasers token xe2 x80 x9d point time scc token repayment consideration unspecified persons considered ico project fits mentioned definitions situation exchange market token legal currencies bitcoin existing cryptocurrencies purposes ico produced funds development stem cell project 1 development introduction payment system cost stem cell treatment hospitals affiliate clinics 2 development introduction pathological diagnostic imaging systems artificial intelligence ai blockchain 3 development virtual clinic platform 4 5 6 costs construction expansion hospitals stem cell treatment research clinical work pharmaceuticalization stem cells xc2 xa9stem cell project 5 x0cbrief overview stem cell coin token stem cell coin currency code scc total number 5 000 000 000 scc max number token sales 1 200 000 000 scc selling price token 1scc 0 06 xe3 x80 x9c0 14usd eth btc neo fluctuate depending sales period type nep5 neo platform token scc maximum token supply 5 000 000 000 scc standard neo nep 5 token minimum purchase 20 000 scc maximum purchase 200 000 000 scc public sale o xef xac x80ering price token $0 14 accepted forms payment btc eth neo privatesale begins october 16 2018 18 00 gmt 4 00 pre ico sale begins 16 2018 18 00 gmt 4 00 pre ico sale ends october 15 2018 18 00 gmt 4 00 privatesale ends october 30 2018 18 00 gmt 4 00 token use utility token unsold tokens burned xc2 xa9stem cell project 6 x0croad map xe3 x83 xbbafter ico period token sales burnt 50% total token xe3 x83 xbbif token sales sold day period selling schedule accelerated xe3 x83 xbbthe schedule content changed depending progress project planning develop singapore regenerative medical center planning develop china regenerative medical center osaka regenerative medical center scheduled open tokyo regenerative medical center scheduled open fukuoka regenerative medical center open kyoto regenerative medical center scheduled open xc2 xa9stem cell project 7 x0cconcepts project industrialized countries including japan increasingly aging populations number people suffering chronic diseases increasing development public transports people don xe2 x80 x99t exercise begin obese metabolic syndrome health maintenance promotion captures interest concept xe2 x80 x9chealth care xe2 x80 x9d important nowadays hand number qualified professionals medical doctors nurses decreasing time wait physical examination doctor getting longer burden medical experts getting heavier year year circumstance develop xe2 x80 x9cai personal doctor xe2 x80 x9d basis concept xe2 x80 x9ceselfcare xe2 x80 x9d health maintenance people world provide xe2 x80 x9caging concept xe2 x80 x9d self maintenance health oneself world 60% 80% world population lack exercise assumed 1 billion people world 60 years old 2025 people tend lack exercise cultures developing result experience body weight gain leads chronic diseases diabetes mellitus hypertension tools lead healthy state maintain state challenge find utilize tools obtain better results healthy 2025 assumed population 60 years old increased addition currently aging industrialized countries developing countries rapid population growth soon aging societies think dreams life peace safe comfortable come true worldwide aging societies reality 8 6 million people world suffer chronic diseases number qualified professionals reducing 8 6 million people world number growing phenomenal speed fact estimated xc2 xbe causes death world chronic disease 2020 chronic diseases managed patients family members health care teams patients enjoy life healthier burden treatment costs minimized additional burden cause crisis xc2 xa9stem cell project according report 2006 need 4 3 million medical doctors nurses medical support staff situation expected improve future insufficient number providing essential medical welfare services 8 x0c2 technologies playing role future health open new doors obtain vital data body temperature blood pressure pulse rate easily need technologies sense physical quantities obtained biological information discarded temporal usage accumulated course followed order happen high security network transfer data freely necessary 2 technologies integrated people xe2 x80 x99s lifestyles environments change significantly change providing future medical services achieved iot blockchain ai personal doctor doctors world oneself vision bring new structure ai blockchain old medical system breakthrough healthcare industry bring affluent society people live health revolutionize medical services ai blockchain revolution doesn xe2 x80 x99t destroy structure current medical services aims complement current services expand breadth example utilization cutting edge sensing technologies chatbots reduce burden medical staff improve accuracy medical examinations application ai analysis blockchain create new medical service area private practice health insurance applicable aim spread world final goal create environment receive high quality medical services labor force medical field decreases population decreases situation condition receive advanced treatment tougher patients improving skills doctors procedures associated medical examinations need reduced xc2 xa9stem cell project 9 x0cbrief overview project stem cell project medical project mainly focused following 2 points development popularization 1 means payment costs stem cell treatment affiliate hospitals 2 pathological diagnostic imaging systems ai blockchain followings 4 main purposes project 1 stem cell treatment possible pay cryptocurrency stem cell therapy helps activate weakened cells proliferate important cells declining number daily stem cell administration cells circulating body finding damaged tissues stem cells activated trying repair regenerate tissues therapy shows promise treatment anti aging diabetes mellitus etc currently stem cell therapy provided medically advanced countries recent years stem cell therapy captured world xe2 x80 x99s attention expecting worldwide financial inflow regenerative medicine means cryptocurrency payment 2 introduction pathological diagnostic imaging systems ai blockchain developing near future health check system share automatic diagnoses images pathological data clinics hospitals world ai blockchain technologies let system grow level screen medical big data rapidly accurately planning use provided big data revealing relationship cancers basis patient information nationality race gender age xc2 xa9stem cell project 10 x0c3 development virtual clinic platform patients experience illness disorders following questions xe2 x80 x9cwhich hospital xe2 x80 x9d xe2 x80 x9cwhich department choose xe2 x80 x9d visiting hospital receiving medicines wasting time burden patients order solve problems develop virtual clinic platform patients feel closer connection doctors network member hospitals clinics japan society aesthetic regenerative medicine aibot diagnosis remote medical checkup system search reservation hospitals clinics payments platform scc xe2 x80 xbbaibot diagnosis ai predict suspected patient xe2 x80 x99s disease s asking questions symptoms affected parts xe2 x80 xbbremote medical checkup system doctors examine patients visit medical institutions reasons living environments video calls etc 4 research clinical work therapeutic formulations stem cells final goal stem cell project xe2 x80 x9cpharmaceuticalization stem cells xe2 x80 x9d research clinical work therapeutic formulations stem cells putting public circulation able achieve aims opportunities need regenerative medicine optimize treatment costs keeping development world xe2 x80 x99s xe2 x80 x9ccell bank xe2 x80 x9d mind create surrounding people diseases treated cells took stored healthy state xc2 xa9stem cell project 11 x0cmore details 1 stem cell therapy attracting worldwide attention recent years therapy currently provided 5 countries germany switzerland russia governmental institutions japan amid increasing demand stem cell therapy especially asia therapy currently provided japan asian nations japan hospitals clinics provide stem cell therapy need obtain approval class ii regenerative medicine accredited ministry health labor welfare project team association medical corporation koge kai planning obtain approval class ii regenerative medicine having clinic stem cell therapy given clinic number people treated payment method treatment costs issue especially china regulation annual limit taking chinese yuan china demand increasing currently difficult bring currency countries treatment costs 6 8 million yen time introduction payment system cryptocurrency solve issue number individual investors holding cryptocurrencies bitcoin growing planning expand customers hospitals affiliate clinics scc payment method xc2 xa9stem cell project 12 x0cmore details 2 final goal system bridge gaps worldwide medical technologies system developed lack medical specialists issue current healthcare industry rare diseases diseases difficult detect tend found thorough examinations university hospitals general hospitals cases detected treated minor hospitals clinics associated major issue lack pathologists similar situation seen medically advanced countries especially china 10 000 pathologists population 1 4 billion scarcity labor result patients gather major hospitals brief overview system data ct x ray images scanned ai system medical big data introduced lead early detection variety diseases detection rare diseases furthermore system blockchain diagnostic data shared medical institutions system lead medical technology improvement minor hospitals developing countries manage high level medical technology gaps medical technology filled system details 3 propose virtual clinic platform patients receive medical services 1 device online variety contents added remote medical checkup system chatbot translation function xc2 xa9stem cell project 13 x0cmore details 4 directly connected point philosophy xe2 x80 x9cregenerative medicine world xe2 x80 x9d stem cell therapy attracting worldwide attention variety symptoms anti aging effect wealthy people receive therapy anti aging high cost stem cell therapy considered therapy patients need issue project aiming xe2 x80 x9coptimize stem cell therapy cost xe2 x80 x9d project team established special technology culture stem cells rapidly accuracy mass culturing possible improving technology optimizing treatment cost opportunities need regenerative medicine aim regenerative medicine closer life pharmaceuticalization stem cells basis research clinical work currently clinics project team provides stem cell treatment approval class ii regenerative medicine accredited ministry health labor welfare approval class regenerative medicine essential pharmaceuticalization stem cells obtain appropriate approval project going provide regenerative medicine people need advantages project providing services healthcare holding medical corporation jsarm clinics team aim raise funds startup like general feature ico grow business introduce operate payment system diagnostic imaging system clinics stem cell project includes medical corporation xc2 xa9stem cell project 14 x0cmarket sizes growth potential regenerative medicine market sizes regenerative medicine 2 5 trillion yen japanese market 38 trillion yen world market 2050 expected enormous economic effects near future 2012 2020 2030 9 billion yen 95 billion yen 1 trillion yen 2050 2 5 trillion yen method calculating market size japan xe2 x80 x9cmarket size regenerative medicine xe2 x80 x9d xe2 x80 x9cno patients 1 xe2 x80 x9d x xe2 x80 x9ccosts patient 2 xe2 x80 x9d 1 xe2 x80 x9cno patients xe2 x80 x9d xe2 x80 x9cno latent patients japan xe2 x80 x9d x xe2 x80 x9capplication rate regenerative medicine xe2 x80 x9d 2 xe2 x80 x9ccosts patient xe2 x80 x9d xe2 x80 x9cunit price products processed products xe2 x80 x9d xe2 x80 x9cmedical charges regenerative medicine eg technical fee xe2 x80 x9d xc2 xa9stem cell project 2012 2020 2030 9 billion yen 95 billion yen 1 trillion yen 2050 2 5 trillion yen method calculating market size world xe2 x80 x9cmarket size country xe2 x80 x9d xe2 x80 x9ccurrent market regenerative medicine country 1 xe2 x80 x9d x xe2 x80 x9cadoption rate regenerative medicine 2 xe2 x80 x9d 1 xe2 x80 x9cno patients xe2 x80 x9d x xe2 x80 x9ccosts patient xe2 x80 x9d method japanese market xe2 x80 x9d 2 estimated population income commodity prices developing items existing market r d budget etc 15 x0cwhat stem cell human body comprised 60 trillion cells 200 types cells type cells role play cells grow hairs cells activate skin cells don xe2 x80 x99t specific role types cells xe2 x80 x9cstem cells xe2 x80 x9d stem cells 1 potential divide repeatedly proliferate type cells 2 potential different types cells stem cells gather damaged area divide proliferate repeatedly facilitates regeneration cells restores tissue functions cell e g fibroblast fertilized egg adult gene transfer stem cells es cell ips cell somatic stem cell cell culture self replication induction multi differentiation multipotential muscle xc2 xa9stem cell project heart bone cartilage blood cells skin nerve liver blood vessel fat etc 16 x0cwhat stem cell therapy stem cell therapy helps activate weakened cells proliferate important cells declining number daily stem cell administration cells circulating body finding damaged tissues stem cells activated trying repair regenerate tissues catching sdf 1 signal damaged area administered stem cells migrating area cells repair area rapidly area hitand run phenomenon stem cells stimulate pituitary gland restores hormonal balance metabolism cycle healthy state recent stem cell researches reveal health organs maintained lifetime permanent regeneration stem cells hand organs tissues aging stem cells aging words medically recognized stem cells play essential role changes caused aging xe2 x80 x9cstem cells xe2 x80 x9d xe2 x80 x9ccore role research aging xe2 x80 x9d feature stem cells regenerate organs damaged illness injury restore functions organs mechanism regenerative medicine stem cell collection impaired organ culture regeneration xc2 xa9stem cell project 17 x0cmaterials research papers images stroke treatment msc adsc comparison mesenchymal stem cells adipose tissue bone marrow ischemic stroke therapy ttc triphenyl tetrazolium chloride dyeing brains 24 hr administrations asc bmsc asc bmsc position 6 position 4 control model ischemic left middle cerebral artery shrinkage infarcted areas obvious asc bmsc cytotherapy 2011 13 675 xe2 x80 x92685 comparison mesenchymal stem cells adipose tissue bone marrow ischemic stroke therapy materials research papers images neurodegenerative treatment adsc xe3 x80 x81msc possibility alzheimer xca xbcs disease treatment human mesenchymal stem cells derived adipose tissue pathological mechanism alzheimer xe2 x80 x99s disease functions adsc msc alzheimer xe2 x80 x99s disease characterized blemish like structure called senile plaques lint like structure called neurofibrillary tangle main component senile plaques xce xb2 amyloid peptide consisting 40 xe2 x80 x9343 amino acids app cleaved xce xb2 amyloid xce xb2 secretase xce xb3 secretase xce xb2 amyloid aggregated precipitated xe2 x86 x93 peptide resulted cleavage amyloid precursor protein app xce xb2 secretase xce xb3 secretase administered stem cells secrete neprilysin affregation precipitation xce xb2 amyloid seen early stage alzheimer xe2 x80 x99s disease considered possible cause xce xb2 amyloid 1 42 accumulated specifically cerebral cortex form senile plaques xce xb2 amyloid 1 40 accumulated cerebral blood vessels cause vascular damage xc2 xa9stem cell project xe2 x86 x93 neprilysin degrades xce xb2 amyloid human adipose tissue derived mesenchymal stem cells secrete functional neprilysin bound exosomes 18 x0cindicated clinical cases 1 indicated clinical case treatment given cancer treatment immunotherapy congenial domains internal medicine orthopedics anesthesiology dermatology depts etc therapy type nk cat therapy xce xb3 xce xb4t cell therapy dendritic cell therapy combination therapy radiation therapy chemotherapy contradiction blood cancer compared solo therapy combination therapy radiation chemotherapy promises adverse effects time effect therapy maximized end stage patients pain relief qol improvement achieved leads improvement qol patient xe2 x80 x99s family members 2 indicated clinical case treatment given diabetes treatment stem cell therapy congenial domains internal medicine diabetic internal medicine endocrine metabolic depts urology plastic surgery internal medicine reproductive medicine etc xe3 x83 xbbpancreas kidneys treatment given patients fall chronic pathological state best early treatment started acute stage early treatment avoids hemodialysis symptoms chronic stage japan deterrence gdp shrink prevention high healthcare costs expected high healthcare costs prevented withdrawal hemodialysis induction differentiation stem cells insulin producing cells cell transplantation income healthcare services pillars industry income tourism targeting diabetes patients economically advanced countries xc2 xa9stem cell project 19 x0c3 indicated clinical case treatment given autoimmune disease stem cell therapy congenial domains collagen disease rheumatology orthopedics depts etc xe3 x83 xbbrheumatism utilization functions stem cells anti inflammation shifting state immunological tolerance state immunological tolerance maintained early reducing stopping progression pathological condition possibility exceeds superiority remicade unknown xe3 x83 xbbbehcet xe2 x80 x99s disease report showing improvement ulcers stomatitis stem cell therapy attributed combination functions anti inflammation immunological tolerance 4 indicated clinical case treatment given stroke treatment stem cell therapy congenial domains internal medicine rehabilitation neurosurgery depts etc stem cells need given 3 months onset stem cells taken acute phase recovery phase cultured immediately cells autotransplanted 3 4 weeks stem cells likely rejected immune system banked transplanted immediately onset order lessening sequelae stem cell transplantation necessary soon possible ideally pharmaceuticalization stem cells expected banking cells hla 3 loci homozygous administration stem cells early stage possible lessens sequalae deterrence gdp shrink prevention high healthcare costs expected xc2 xa9stem cell project 20 x0c5 indicated clinical case treatment given r d hair regeneration baldness treatment stem cell therapy congenial domains internal medicine surgery plastic surgery dermatology depts etc stem cell therapy alopecia combination use internal medicines propecia possible therapy research development established complete treatment global demand main projects company marketing especially wealthy people world bring sufficient number patients kyocera corporation organ technologies inc aim technology alopecia practical use 2020 6 indicated clinical case treatment given r d cell banking system cord blood stem cells congenial domains maternity gynecology internal medicine surgery plastic surgery depts etc patients suffering stroke spinal cord injury stem cell transplantation provided early stage possible lessen sequelae securement certain number cells hla 3 loci homozygous enables provide stem cell formulation majority japanese people immunorejection storage cord blood supply source cases leukemia xc2 xa9stem cell project 21 x0c7 indicated clinical case treatment given angiopathy stem cell therapy congenial domains cardiovascular vascular surgery plastic surgery depts etc stem cell therapy agiopathy buerger xe2 x80 x99s disease aso applicable rare diseases diabetic patients xe2 x80 x99 peripheral vascular disorder therapy achieve course improvement patients xe2 x80 x99 qol demand boosting countries indicated clinical case r d psychiatric neurological disorders stem cell therapy congenial domains internal medicine psychiatry neurology cranial nerve internal medicine dept etc xe3 x83 xbblymphocytes r d clinical study medicinal treatment depression autism withdrawal therapeutic medication xce xb2 endorphin facilitates pain relief increased activity time xe3 x83 xbbstem cell therapy r d clinical study treatment neurodegenerative diseases alzheimer xe2 x80 x99s disease als parkinson disease pilio xc2 xa9stem cell project 22 x0cpathological diagnostic imaging systems ai blockchain deep learning greatly developed currently gathering attentions areas tremendous improvement computer performance collection big data spread world wide web internet devices research outcomes deep learning overwhelming recognition performance especially field pathology image recognition imagenet large scale visual recognition challenge ilsvrc competitions recognition accuracy generic object images held accuracy kept greatly improving 2012 deep learning introduced eventually 2015 overtook human recognition performance deep learning applied variety fields healthcare blockchain deep learning comparing computational techniques achieve great accuracy order gain accuracy requires great deal leaning time currently available high speed calculators instance google spent 1 000 xe2 x80 x93 2 000 hours learning time achieve 99 63% ultrahigh accuracy convolutional neural network facenet recognizes human face images going handle bigger blockchain network lead complete solutions medical issues deep learning terms future issues considered practical issue learnt longer time purpose reduce leaning time drastically accelerating leaning speed experiment started turning algorithm speeding deep learning reality idea new architecture data flow distributed memory keyword xe2 x80 x9cparallelization xe2 x80 x9d current stage provide aforementioned pathological imaging diagnosis capillary diagnosis medical practice aim high throughput high power efficiency small temporal granularity achieving high speed learning dedicated processors xc2 xa9stem cell project 23 x0cissues faced health industry xe2 x97 x87 limited number radiologists pathologists japan 6 334 radiologists 2 232 pathologists japanese board medical specialties 2013 cf china 50 000 radiologists incl technicians 10 000 pathologists xe2 x86 x92 issue regional difference difference hospitals cancer treatment xe2 x86 x92 reaching critical limits traditional model pathologists xe2 x80 x99 work institutions sticking xe2 x80 x9creal material samples xe2 x80 x9d transition digitalization pathological examinations order facilitate transition radiology depts given preferential national health insurance points choose digital data storage film storage xe2 x97 x87 number patients cancer lifestyle related diseases growing aging society increase city population validation results based pathological data benefit xe2 x97 x87 diagnostic accuracy colorectal cancer 99 9% xe2 x97 x87 validated images past 1 865 diagnosed cases osaka university xe2 x97 x87 0 1% cases poorly differentiated type xe2 x85 xa1 difficult experienced pathologists xe2 x97 x87 examination time approx 5 sec diagnosis commonly marketed pc xe2 x97 x87 fp detect 43 5% j diagnostic pathology 2015 system screening double check remote pathological image diagnosis etc colorectal cancer stomach cancer etc xc2 xa9stem cell project 24 x0cissues faced health industry 1 cost saving pathological diagnosis xe2 x97 x87 improvement diagnostic efficiency prevention missing cancer diagnoses automatic screening digital images double check function automated pathological service applied mathematics apsam xe2 x97 x87 cost saving hospital saving storage space pathological samples digitalization increase income remote pathological diagnosis 2 solution limited number pathologists xe2 x97 x87 developed regions saving labor pathologists making double check diagnoses happen xe2 x97 x87 developing countries improvement levels pathological diagnosis hospitals having veteran pathologists offering remote pathological services hospitals having pathologists improvement quality medical services educational tools 3 homogenization treatment level sharing diagnostic criteria 4 development processing methods big data pathological images xe2 x97 x87 indexing pathological image data enables process medical big data contributes improvement medical services source xef xbc x9amarketsandmarkets digital pathology market unit 100 million yen digital pathology market cagr leading countries 15 8% 12 000 12 9% 13 8% 14 9% 16 0% 13 5% 9 000 12 0% 6 000 8 0% 3 000 4 0% 0 england 2011 cagr 2013 2018 xc2 xa9stem cell project germany 2012 china 2013 japan 0 0% 2018 25 x0cglobal needs pricing increase number cancer patients xe2 x97 x87 developed countries japan tendency aging population increase number cancer patients expected xe2 x97 x87 according improvement healthcare system major diseases causing death e g infection decreasing developing countries xe2 x97 x87 cancer disease haven xe2 x80 x99t overcome complete cure achieved treatment appropriately given xe2 x97 x87 phathologists indicate treatment methods require sufficient training needs pathologists world xe2 x97 x87 developed countries computer aided systems necessary busy schedule xe2 x97 x87 developing countries pathologists xe2 x86 x92 support system necessary possible system determine certain level pathology xe2 x97 x87 important systems cover support improvement infrastructure e g remote diagnosis pricing xe2 x97 x87 usage charge apsam covered social insurance xe2 x97 x87it difficult fix price pathologists different status role country xe2 x97 x87 point time 30% 40% payment pathological diagnosis considered cost patient xe2 x97 x87 usually 90% pathological sample normal development system extract abnormal parts contributes improvement pathological diagnostic efficiency light set price comparison actual hiring cost pathologist xc2 xa9stem cell project 26 x0cconcept virtual clinic platform patients experience illness disorders following questions xe2 x80 x9cwhich hospital xe2 x80 x9d xe2 x80 x9cwhich department choose xe2 x80 x9d visiting hospital receiving medicines wasting time burden patients order solve problems develop virtual clinic platform patients feel closer connection doctors network member hospitals clinics japan society aesthetic regenerative medicine aibot diagnosis remote medical checkup system search reservation hospitals clinics contents added platform create environment patients easily receive medical services online payments platform scc process reservation payment medical examination online patients receive medicines prescription home storage medicines sales managed time patients visiting hospital use ble system registration card xc2 xa9stem cell project 27 x0cfrom world japan japan leading center medical tourism xe2 x80 x9d xe2 x97 x8f xe2 x97 x8f xe2 x97 x8f xe2 x97 x8f xe2 x97 x8f xe2 x97 x8f create system country xe2 x80 x99s version disseminate information japanese advanced medical care system responsive requests remote diagnosis countries world 24 hours day facilitate medical related services e g medical checkup treatment targeting asian wealthy people collaboration travel agencies medical tourism companies groups patients consult healthcare professional health problems away home e g foreigners living visiting japan ask xe2 x80 x9cwhere regular medicine xe2 x80 x9d xe2 x80 x9dmy physical condition suddenly gets worse xe2 x80 x9d etc need choose healthcare professional online app consult healthcare professional mother tongue referral form needed issued language country xe2 x9c x93 don xe2 x80 x99t need worry case sudden aggravation physical condition consult healthcare professional trip change physical condition run regular medicines etc xe2 x9c x93 reachable 24 7 smart phone variety healthcare professionals waiting xe2 x9c x93 talk mother tongue choose right healthcare professional language levels profession etc listed xe2 x9c x93 emergency illness symptoms acceptable tell symptoms personal data hospital provide referral form medical information language country xc2 xa9stem cell project 28 x0csensor network sensor network cognizes xe2 x80 x99s circumstances autonomously cooperates essential technology realize healthy wealthy society applied wide range areas healthcare welfare crime prevention security disaster prevention environmental risks developing future social economic activities doctor constant collection major biological information e g pulse bt bp o2 blood data base useful doctors decision sensor network change healthcare services family family know person receiving biological information family person connecting network pharmacist physiotherapist based biological information efficiency prescribed medicine s checked compared past data pharmacists prescribe appropriate medicine s patient physiotherapists know patient exercise consuming energy away patient patient appropriate advice knowing exercise level person sensor network noticing purpose virtual clinic miniaturization communication function devices main points future key technology xc2 xa9stem cell project care welfare services connecting network care workers check patients xe2 x80 x99 conditions time communication medical institutions nursing homes smooth lessens burden carers 29 x0cour society established purpose contribution development regenerative medicine japan improvement dissemination research regenerative medicine practices publication communication exchange knowledge named society xe2 x80 x9caesthetic xe2 x80 x9d doesn xe2 x80 x99t mean dedicated cosmetic medicine use word xe2 x80 x9caesthetic xe2 x80 x9d develop society multiple fields regenerative medicine including cosmetic medicine course going mention alternatives new treatment centering dentistry light conditions times activities working societies organizations include providing advice observational studies medical guidelines applicable regenerative medicine law regard healthcare studies applicable laws regenerative medicine clinical studies cooperate certified special committee regenerative medicine certified committee regenerative medicine certified review board research ethics committee working group knowledgeable people human pluripotent stem cells cell culturing organized miho furue human stem cell applied research room national institutes biomedical innovation health nutrition project leader regenerative medicine practical project xe2 x80 x9ca study standardization culturing technique aiming quality variability practical application ips cells xe2 x80 x9d japan agency medical research development amed group proposed following 5 conditions xe2 x80 x9cfundamental principles cell culturing xe2 x80 x9d 1st condition recognize cell culturing derived living body 2nd condition confirm reliability source applicability methods 3rd condition prevent contamination culturing cells 4th condition manage culturing cells handling record properly 5th condition consider health safety culturing technicians environmental effect xc2 xa9stem cell project 30 x0cwe comply 5 conditions affiliate cell processing center approved regenerative medicine ensuring safety law article 40 clause1 preparing suppling cell processed products physiologically active materials e g culture supernatant adequately preparing providing genetic treatment remote diagnosis immunotherapy flora therapy etc studies medical practice based law course need comply guideline field partly legislated law guidelines xe2 x80 x9cduty education training xe2 x80 x9d listed common order exercise duty going training workshops looking people support proper dissemination regenerative medicine provide study cases teach field head director shuji yamaguchi internal medicine doctor dermatologist ent doctor ophthalmologist cosmetic surgeon regenerative medicine doctor integrative medicine doctor dentist chinese medicine doctor vet etc health beauty industry exercise instructor judo therapist chiropractor welfare caretaker aromatherapist aesthetician etc xc2 xa9stem cell project doctor health fitness industry paramedical company nurse clinical laboratory technician nutritionist pharmacist physiotherapist health nurse dental hygienist dental technician midwife psychotherapist etc civil service medical manufacturer supplement health applicant manufacturer sports applicant manufacturer beauty manufacturer etc 31 x0cbusiness expansion map early step 1 year xef xbc x89 xe2 x80 xa2 stabilization operation healthcare institution xe2 x80 xa2 consolidation protocol sales expanding step 1 3 years xe2 x80 xa2 development clinics xe2 x80 xa2 spreading clinics cpc major cities xe2 x80 xa2 expansion cpc instruments xe2 x80 xa2 technology overseas transfer 3 years affiliation overseas healthcare institutions technology transfer business expansion regenerative medical institutions direct management clinics holding class ii regenerative medicine high end cancer treatment providing highest cancer treatment class iii regenerative medicine cases stem cell therapy selling clinical trials pharmaceutical manufacturers technology transfer overseas stem cell therapy providing treatment associated clinics c e l l c u l t u r n g c e l l p ro c e s s n g commissioned project group companies stem cell supernatant medical institutions supplying therapeutic medicine cell bank foreign tourism current mri ct stem cell culture media supplying cosmetic manufacturers xc2 xa9stem cell project 32 x0cbrief overview token sale procurement funds ico mainly research development project foundations service clinics ai technology blockchain technology development requires large money funds appropriately distributed accordance procurement funds development cost purpose funds 5% 15% 35% 20% 25% expansion hospitals research system development marketing legal work management cost xc2 xa9stem cell project 33 x0ctoken distribution procurement funds ico mainly research development project foundations service clinics ai technology blockchain technology development requires large money funds appropriately distributed accordance procurement funds development cost 20% 50% 30% ico sale token development xc2 xa9stem cell project held team 34 x0cbonuses major token holders major token holders given bonuses receive following stem cell treatments 6 million yen healthcare institutions group bonuses given purchase tokens ico period xe3 x80 x90over 200 000 token holder xe3 x80 x91 20% stem cell treatment 1 time xe3 x80 x90over 1 000 000 token holder xe3 x80 x91 50% stem cell treatment 1 time xe3 x80 x90over 2 000 000 token holder xe3 x80 x91 free stem cell treatment 1 time bonuses long term token holders 6 month holders healthcare point given holding token healthcare point given holding token sold money transferred 6 months xe2 x86 x93 points payment treatment affiliate hospitals clinics holding token 6 months healthcare point given healthcare point given 6month holders payment treatment affiliate hospitals clinics 6 months day given available clinics updated website needed healthcare point 6 months automatically swapped token given wallet xc2 xa9stem cell project 35 x0caffiliate teams total issuance mta intec pte ltd singapore corporation address 10 anson road 18 03 international plaza singapore 079903 website https www stemcell pj net business development chief director medical corporation koge kai medical service developer world agent co ltd system developer shoji yamaguchi security team order avoid hacking ai systemsecurity monitored strengthened team blockchain team scc implemented team basis concept stem cell project team implement private blockchain marketing team team plays key role formulation advertisement strategy stem cell project branding information transmission xc2 xa9stem cell project 36 x0cdisclaimer document information purposes intended solicit sale related companies xe2 x80 x99 shares securities solicitation shall place accordance provisions law information analysis presented basis investment decisions specific recommendations document constitute investment advice recommendations investment solicitations document intended solicitation sale securities purchase securities addition document submitted registered regulatory authorities reviewed confirmed regulatory authorities planned submitted registered regulatory authorities shall liable loss damage kind directly indirectly resulting error omission inaccuracy information contained furthermore information contained document changed prior notice future restrictions purchasers xe3 x83 xbb nationals residents state purchase stem cell coin token issued mta intec pte ltd hereinafter xe2 x80 x9cscc token xe2 x80 x9d similar token prohibited including limited people s republic china purchaser subject laws nationals residents european economic area members european union iceland liechtenstein norway purchase scc token xe3 x83 xbb purchase scc token shall individuals entities enterprises extensive experience token block chain based software systems knowledge use complexity xe3 x83 xbb purchaser understand storage method transmission mechanisms scc token tokens xe3 x83 xbb parties associated shall liable loss scc token purchaser reason whatsoever xe3 x83 xbb scc token purchased purchaser required experience expertise xe3 x83 xbb purchasing scc token purchase shall careful consideration risks costs purchase disadvantages xe3 x83 xbb event purchaser mentioned experience expertise required consideration purchaser obtain advice experts points purchaser purchase scc token purchaser understands reviews items stated risks purchasing scc token risks related purchase scc token situation purchaser accept advice xe3 x83 xbb determine purchaser breach representations warranties set forth xe2 x80 x9c representations warranties scc token purchaser xe2 x80 x9d set forth purchaser purchase scc token risks purchasing scc token purchase scc token poses significant risks purchasing scc token purchaser carefully consider risks listed consult attorney accountant tax accountant expert extent necessary issues xc2 xa9stem cell project 37 x0cthat understood note purchase scc token purchaser definitive intent purchase refunded event case allowed risks inherent blockchain technology xe3 x83 xbb blockchain technologies subject scrutiny regulatory agencies world scc token xef xac x80ected regulatory inquiries actions legal amendments interfere restrict issuance distribution exchange scc token xe3 x83 xbb party access user s account information private key operate scc token information known party risk lead loss scc token order minimize risk purchaser measures protecting electronic devices unauthorized access risks fluctuations value scc token xe3 x83 xbb like tokens value scc token vary considerably reduced variety reasons xe3 x83 xbb use best e xef xac x80orts guarantee creation token economies associated scc token hereinafter referred scc token economy purchaser understand liquidity scc token lower expect use adoption scc token inadequate little market platform startup value scc token limited addition scc token economy su xef xac x80er systemic failures result decline value scc token xe3 x83 xbb benefits rights purchaser enjoy owning scc token determined purchaser time purchasing scc token depend development business managed operated scc token economy currently planning stage subject significant changes prior release expectations format functionality scc token held time purchase met time release reasons including changes design implementation plans establishment execution scc token economies use best e xef xac x80orts guarantee benefits rights purchaser expects timing content purchaser enjoy matters related benefits rights risks based external factors xe3 x83 xbb hackers groups organizations attempt disrupt availability scc token economies scc token variety ways including denial service attacks sybil attacks spoofing smurfing malware attacks agreed attacks xe3 x83 xbb technological advances advances cryptography development quantum computers pose risks cryptography field scc token economy result theft loss scc token risks xe3 x83 xbb unlike financial institutions bank accounts accounts funds held scc token insured remedy public insurance company private insurance xc2 xa9stem cell project 38 x0ccompany event loss loss value xe3 x83 xbb scc token economy impracticable dissolved number reasons including limited adverse fluctuations value scc token inadequate business relationships xe3 x83 xbb cryptographic token new technology addition risks listed risks anticipate unexpected combinations variations risks described xef xac x80ect value scc token risk apparent disclaimer disclaimer warranties xe3 x83 xbbwe sell scc token extent available warranty kind expressly disclaims implied warranties including limitation implied warranties merchantability fitness specific purpose title non infringement respect scc token xe3 x83 xbbwe representation warranty scc token reliable current error free meets conditions required purchaser defects scc token corrected future xe3 x83 xbbwe representation warranty mechanism delivery scc token scc token xef xac x80ected viruses harmful components xe3 x83 xbbwe intend disclaims representation warranty promise kind including representation warranty promise truth accuracy completeness information contained document web site etc xe3 x83 xbbwe warrant estimated present value scc token information provided information obtained purchaser scc token conform specific purpose purchaser expected function merchandising value accuracy usefulness completeness purchase scc token conform applicable laws regulations internal rules trade associations applicable purchaser cause defects resolve problems related scc token xe3 x83 xbbwe related companies shall liable damages incurred purchaser connection purchase scc token accordance provisions consumer contract act reasons related companies liable purchaser damages scope liability shall limited direct ordinary damages actually incurred reason attributable related companies upper limit damages shall purchase price scc token purchaser xe3 x83 xbbthe purchaser shall responsible taxes including limited consumption tax sales tax use tax value added tax etc imposed purchase scc token responsibility purchaser withhold collect correct tax report pay properly responsible withholding collection reporting payment taxes purchase scc token representations warranties scc token purchaser purchasing scc token purchaser represents warrants xe2 x96 xa0 purchaser subject purchase restrictions set forth restrictions purchasers authority capacity lawfully purchase scc token xe2 x96 xa0 purchaser shall fully understand xe2 x80 x9crisks purchasing scc token xe2 x80 x9d set forth xc2 xa9stem cell project 39 x0cabove risks disadvantages associated purchasing scc token shall purchase scc token responsibility determine purchase scc token appropriate purchaser xe2 x96 xa0the purchaser purchases scc token behalf act agent party xe2 x96 xa0the purchaser agrees acknowledges scc token constitute form securities purchaser s jurisdictions xe2 x96 xa0the purchaser agrees acknowledges intended promotional activities scc token result solicitation securities investment securities purchaser s territory xe2 x96 xa0purchase scc token prohibited restricted law regulation purchaser s territory purchase ownership scc token restricted purchaser shall comply restriction expense incurring liability related companies xe2 x96 xa0the purchaser agrees acknowledges time purchasing scc token scc token classified treated following virtual currency prescribed article 2 paragraph 5 payment services act means payment advance prescribed article 3 paragraph 1 payment services act legal currency deemed currency prescribed japan state bonds issued related companies shares controlling interests issued related companies right option derivative instrument respect bond share share certificate rights cdf contracts contracts purpose securing profits avoiding losses equity collective investment schemes equity business trust derivatives equity interests business trusts types securities xe2 x96 xa0the purchaser fully understands operation function use storage transmission mechanism significant features virtual currency blockchain based software systems virtual currency wallets relevant token storage mechanisms block chain technology smart contract technology xe2 x96 xa0the purchaser fully understands risks associated business operations xe2 x96 xa0the purchaser agrees acknowledges related companies shall liable indirect extraordinary contingent consequential loss kind including limitation loss revenue income profit loss inability data arising connection purchaser s purchase scc token tort contract xe2 x96 xa0the purchaser use scc token unlawful conduct including limited money laundering terrorist financing xe2 x96 xa0we related companies shall liable damages whatsoever incurred purchaser respect matters represented warranted purchaser risks disadvantages associated purchase scc token explained purchaser reason whatsoever purchaser shall hold related companies harmless matters xc2 xa9stem cell project 40 x0c